These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 19075641)
1. Thioredoxin-1 is a novel and attractive therapeutic approach for various diseases including cardiovascular disorders. Billiet L; Rouis M Cardiovasc Hematol Disord Drug Targets; 2008 Dec; 8(4):293-6. PubMed ID: 19075641 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin. Schulze PC; De Keulenaer GW; Yoshioka J; Kassik KA; Lee RT Circ Res; 2002 Oct; 91(8):689-95. PubMed ID: 12386145 [TBL] [Abstract][Full Text] [Related]
3. Thioredoxin and redox signaling: Roles of the thioredoxin system in control of cell fate. Matsuzawa A Arch Biochem Biophys; 2017 Mar; 617():101-105. PubMed ID: 27665998 [TBL] [Abstract][Full Text] [Related]
6. Thioredoxin in vascular biology: role in hypertension. Ebrahimian T; Touyz RM Antioxid Redox Signal; 2008 Jun; 10(6):1127-36. PubMed ID: 18315495 [TBL] [Abstract][Full Text] [Related]
7. The thioredoxin system as a therapeutic target in human health and disease. Mahmood DF; Abderrazak A; El Hadri K; Simmet T; Rouis M Antioxid Redox Signal; 2013 Oct; 19(11):1266-303. PubMed ID: 23244617 [TBL] [Abstract][Full Text] [Related]
8. The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein. Hwang J; Suh HW; Jeon YH; Hwang E; Nguyen LT; Yeom J; Lee SG; Lee C; Kim KJ; Kang BS; Jeong JO; Oh TK; Choi I; Lee JO; Kim MH Nat Commun; 2014; 5():2958. PubMed ID: 24389582 [TBL] [Abstract][Full Text] [Related]
9. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372 [TBL] [Abstract][Full Text] [Related]
10. Redox control of cellular function by thioredoxin; a new therapeutic direction in host defence. Nishinaka Y; Nakamura H; Masutani H; Yodoi J Arch Immunol Ther Exp (Warsz); 2001; 49(4):285-92. PubMed ID: 11726031 [TBL] [Abstract][Full Text] [Related]
11. Diabetes impairs exercise training-associated thioredoxin response and glutathione status in rat brain. Lappalainen Z; Lappalainen J; Oksala NK; Laaksonen DE; Khanna S; Sen CK; Atalay M J Appl Physiol (1985); 2009 Feb; 106(2):461-7. PubMed ID: 19074570 [TBL] [Abstract][Full Text] [Related]
12. Role of thioredoxin in lung disease. Xu J; Li T; Wu H; Xu T Pulm Pharmacol Ther; 2012 Apr; 25(2):154-62. PubMed ID: 22293327 [TBL] [Abstract][Full Text] [Related]
13. Thioredoxin in the cardiovascular system. World CJ; Yamawaki H; Berk BC J Mol Med (Berl); 2006 Dec; 84(12):997-1003. PubMed ID: 17021908 [TBL] [Abstract][Full Text] [Related]
14. Acute exercise and thioredoxin-1 in rat brain, and alpha-lipoic acid and thioredoxin-interacting protein response, in diabetes. Lappalainen Z; Lappalainen J; Laaksonen DE; Oksala KJ; Khanna S; Sen CK; Atalay M Int J Sport Nutr Exerc Metab; 2010 Jun; 20(3):206-15. PubMed ID: 20601738 [TBL] [Abstract][Full Text] [Related]
15. The thioredoxin antioxidant system. Lu J; Holmgren A Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of antioxidant thioredoxin by antidepressants fluoxetine and venlafaxine. Bharti V; Tan H; Deol J; Wu Z; Wang JF Psychopharmacology (Berl); 2020 Jan; 237(1):127-136. PubMed ID: 31473777 [TBL] [Abstract][Full Text] [Related]